Healthy Extracts Revenue Doubles Following Strategic Beauty Acquisition
Las Vegas, Saturday, 15 August 2026.
Healthy Extracts achieved record Q2 2026 revenue of $2.1 million, driven by acquiring Imaraïs Beauty. Despite higher operating expenses causing a net loss, gross margins expanded significantly to 70.3%.
Record Revenue Driven by Strategic Acquisition
Healthy Extracts Inc. (OTCQB: HYEX) reported a significant surge in financial performance for the second quarter of 2026, with net revenue reaching a record $2.1 million [1][3][4]. This figure represents a 113% year-over-year increase compared to the $968,656 recorded in the same period of 2025, calculated as 113.41 percent growth based on precise filing data [2]. The substantial revenue expansion is primarily attributed to the company’s strategic acquisition of Imaraïs Beauty, finalized in May 2026, which integrated a global beauty brand into its portfolio [1][4]. This acquisition follows a merger with Gummy USA in October 2025, compounding the company’s market penetration efforts leading into the second quarter ending June 30, 2026 [3][4].
Profitability Metrics and Operational Costs
While top-line growth was robust, gross profit for Q2 2026 rose 145% to $1.5 million, with gross margins expanding from 61.2% to 70.3% [1][3]. This margin improvement is expressed by the calculation 152.951 percent when comparing current gross profit to the $593,000 reported in Q2 2025 [4]. Despite the revenue and gross profit gains, the company reported a net loss of $129,000 for the quarter, contrasting with a net income of $67,000 in the prior-year period [2][3]. Adjusted EBITDA improved to $290,000, up from an adjusted loss of $25,000 in Q2 2025, indicating progress in operational efficiency despite higher operating expenses driven by salaries and stock-based compensation [1][4].
Liquidity Position and Debt Obligations
As of June 30, 2026, Healthy Extracts held $190,000 in cash, an increase from the $147,000 recorded at the end of 2025 [2][4]. However, the company faces significant liquidity challenges, including an accumulated deficit of $20.45 million and a disclosed going concern risk dependent on raising additional capital [2]. Several debt obligations are overdue relative to the current date of August 15, 2026, including Debt N which matured on July 20, 2026, and Debt I which matured on June 30, 2025 [2]. Total liabilities increased significantly to $10.17 million compared to $3.8 million at the end of 2025, highlighting the financial leverage utilized during recent expansion phases [2].
Future Outlook and Regulatory Filings
Management aims to achieve annualized net revenue of more than $20 million by December 31, 2026, representing a threefold increase over the previous year [3][4]. These preliminary unaudited results are subject to revision until the company officially files its Form 10-Q with the U.S. Securities and Exchange Commission [3]. The company acknowledges that meeting debt obligations will require raising significant capital, with no assurance of success in these efforts [2]. Internal control disclosures noted that disclosure controls and procedures were not effective at the reasonable assurance level as of June 30, 2026 [2].